Cardiol Therapeutics Inc. (CRDL)
NASDAQ: CRDL · Real-Time Price · USD
1.940
+0.060 (3.19%)
Aug 30, 2024, 4:00 PM EDT - Market closed
Cardiol Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
6
Market Cap
135.16M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
InfuSystem Holdings | 129.37M |
Harvard Bioscience | 101.13M |
Repare Therapeutics | 68.68M |
Electromed | 54.72M |
BrainsWay | 36.43M |
Elutia | 24.99M |
CervoMed | 9.65M |
Quantum-Si incorporated | 1.70M |
CRDL News
- 2 months ago - Cardiol Therapeutics Reports Results of 2024 Annual General and Special Meeting of Shareholders - Newsfile Corp
- 2 months ago - Cardiol Therapeutics to Webcast Virtual Annual General and Special Meeting of Shareholders on June 26th at 4:30 p.m. EDT - Newsfile Corp
- 2 months ago - Cardiol Therapeutics Announces Positive Topline Data from its Phase II MAvERIC-Pilot Study Investigating CardiolRx(TM) for Recurrent Pericarditis - Newsfile Corp
- 3 months ago - Cardiol Therapeutics Announces Phase II ARCHER Trial Presented at the World Congress on Acute Heart Failure 2024 - Newsfile Corp
- 5 months ago - Cardiol Therapeutics Announces Year-End 2023 Update on Operations - Newsfile Corp
- 6 months ago - Cardiol Therapeutics Completes Patient Enrollment in its Phase II MAvERIC-Pilot Study Investigating CardiolRx(TM) for Recurrent Pericarditis - Newsfile Corp
- 7 months ago - Cardiol Therapeutics Granted Orphan Drug Designation for its Lead Drug Candidate for the Treatment of Pericarditis - Newsfile Corp
- 7 months ago - Cardiol Therapeutics Regains Compliance with all Applicable Listing Standards of The Nasdaq Capital Market - Newsfile Corp